{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:50:05Z","timestamp":1793958605035,"version":"4.8.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100001512","name":"National Brain Tumor Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001794","name":"Pediatric Brain Tumor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Central Brain Tumor Registry of the United States (CBTRUS), an aggregation of data from the Centers for Disease Control and Prevention\u2019s National Program of Cancer Registries and the National Cancer Institute\u2019s Surveillance, Epidemiology and End Results program, is the largest population-based registry focused exclusively on primary brain and other central nervous system (CNS) tumors in the United States (US). As of this report, the CBTRUS database represents the entire US population. This report contains the most up-to-date population-based data on primary brain tumors and supersedes all previous reports in terms of completeness and accuracy. All rates are age-adjusted using the 2000 US standard population and presented per 100,000 population. Between 2018 and 2022, the average annual age-adjusted incidence rate (AAAIR) of all primary malignant and non-malignant brain and other CNS tumors was 26.05 per 100,000 population (malignant AAAIR=6.86 and non-malignant AAAIR=19.19). Incidence was higher in women compared to men (29.67 versus 22.23 per 100,000) and in non-Hispanic Black individuals compared to non-Hispanic White (27.40 versus 26.36 per 100,000), non-Hispanic American Indian\/Alaska Native (24.38 per 100,000), non-Hispanic Asian or Pacific Islander (20.42 per 100,000), and Hispanic individuals of all races (24.69 per 100,000). Gliomas accounted for 22.2% of all tumors. The most commonly occurring malignant brain and other CNS histopathology was glioblastoma (13.7% of all tumors and 52.2% of all malignant tumors), and the most common non-malignant histopathology was meningioma (42.6% of all tumors [includes malignant meningioma] and 57.4% of all non-malignant tumors). Glioblastoma was more common in men, and meningioma was more common in women. In children and adolescents (ages 0-19 years), the incidence rate of all primary brain and other CNS tumors was 5.99 per 100,000 population. Overall, there were 88,186 total deaths attributed to &amp;#x2028;malignant brain and other CNS tumors between 2018 and 2022, representing an average of 17,637 deaths per year and an average annual mortality rate of 4.41 per 100,000 population. The five-year relative survival rate following diagnosis of a malignant brain or other CNS tumor was 34.8%, while it was 91.7% for a non-malignant brain or other CNS tumor.<\/jats:p>","DOI":"10.1093\/neuonc\/noaf194","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:37:08Z","timestamp":1760553428000},"page":"iv1-iv66","source":"Crossref","is-referenced-by-count":227,"title":["CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2018\u20132022"],"prefix":"10.1093","volume":"27","author":[{"given":"Mackenzie","family":"Price","sequence":"first","affiliation":[{"name":"Central Brain Tumor Registry of the United States , Hinsdale, IL ,","place":["U.S.A"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine Ann Pittman","family":"Ballard","sequence":"additional","affiliation":[{"name":"Central Brain Tumor Registry of the United States , Hinsdale, IL ,","place":["U.S.A"]},{"name":"Department of Neurosurgery, Duke University School of Medicine , Durham, NC ,","place":["U.S.A"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia R","family":"Benedetti","sequence":"additional","affiliation":[{"name":"Central Brain Tumor Registry of the United States , Hinsdale, IL ,","place":["U.S.A"]},{"name":"Department of Neurosurgery, Duke University School of Medicine , Durham, NC ,","place":["U.S.A"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Kruchko","sequence":"additional","affiliation":[{"name":"Central Brain Tumor Registry of the United States , Hinsdale, IL ,","place":["U.S.A"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill S","family":"Barnholtz-Sloan","sequence":"additional","affiliation":[{"name":"Central Brain Tumor Registry of the United States , Hinsdale, IL ,","place":["U.S.A"]},{"name":"Winship Cancer Institute, Emory University , Atlanta, GA ,","place":["U.S.A"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinn T","family":"Ostrom","sequence":"additional","affiliation":[{"name":"Central Brain Tumor Registry of the United States , Hinsdale, IL ,","place":["U.S.A"]},{"name":"Department of Neurosurgery, Duke University School of Medicine , Durham, NC ,","place":["U.S.A"]},{"name":"The Preston Robert Tisch Brain Tumor Center, Duke University School of Medicine , Durham, NC ,","place":["U.S.A"]},{"name":"Duke Cancer Institute, Duke University Medical Center , Durham, NC ,","place":["U.S.A"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"3","key":"2025101611114398300_CIT0001","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/neuonc\/noy006","article-title":"The CBTRUS story: providing accurate population-based statistics on brain and other central nervous system tumors for everyone","volume":"20","author":"Kruchko","year":"2018","journal-title":"Neuro Oncol"},{"key":"2025101611114398300_CIT0002","volume-title":"R: A Language and Environment for Statistical Computing: R Foundation for Statistical Computing","author":"Team RC","year":"2025"},{"key":"2025101611114398300_CIT0003","volume-title":"WHO Classification of Tumours of the Central Nervous System","author":"Louis","year":"2016"},{"issue":"4","key":"2025101611114398300_CIT0004","first-page":"317","article-title":"Aligning the Central Brain Tumor Registry of the United States (CBTRUS) histology groupings with current definitions","volume":"9","author":"Waite","year":"2022","journal-title":"Neurooncol. Pract"},{"key":"2025101611114398300_CIT0005","author":"and CfDC, Prevention","year":"2024"},{"key":"2025101611114398300_CIT0006","author":"Centers for Disease Control and Prevention (CDC)","year":"1999"},{"key":"2025101611114398300_CIT0007","year":"1992"},{"key":"2025101611114398300_CIT0008","year":"2002"},{"key":"2025101611114398300_CIT0009","author":"National Cancer Institute"},{"key":"2025101611114398300_CIT0010","volume-title":"National Program of Cancer Registries and Surveillance, Epidemiology, and End Results Program SEER*Stat Database: NPCR and SEER Incidence\u2014U.S. Cancer Statistics Public Use Research Database, 2024 submission (2001\u20132022). United States Department of Health and Human Services","year":"2025"},{"issue":"7","key":"2025101611114398300_CIT0011","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: a \u201cstate of the science\u201d review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro-Oncology"},{"issue":"12","key":"2025101611114398300_CIT0012","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1158\/1055-9965.EPI-14-0207","article-title":"Childhood Brain Tumor Epidemiology: A Brain Tumor Epidemiology Consortium Review","volume":"23","author":"Johnson","year":"2014","journal-title":"Cancer Epidemiology Biomarkers & Prevention"},{"key":"2025101611114398300_CIT0013","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/neuonc\/noz123","article-title":"Risk factors for childhood and adult primary brain tumors","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro Oncol"},{"issue":"3","key":"2025101611114398300_CIT0014","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and etiology of meningioma","volume":"99","author":"Wiemels","year":"2010","journal-title":"J. Neurooncol"},{"key":"2025101611114398300_CIT0015","article-title":"SEER*Stat Database: NPCR Survival and Prevalence Analytic file 2001-2021. United States Department of Health and Human Services, Centers for Disease Control and Prevention","author":"National Program of Cancer Registries"},{"key":"2025101611114398300_CIT0016","author":"Surveillance Epidemiology and End Results (SEER) Program","year":"2025"},{"key":"2025101611114398300_CIT0017","author":"Surveillance Epidemiology and End Results (SEER) Program","year":"2025"},{"key":"2025101611114398300_CIT0018","volume-title":"International Classification of Diseases for Oncology","author":"Fritz","year":"2000"},{"issue":"2","key":"2025101611114398300_CIT0019","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1215\/15228517-4-2-134","article-title":"Consensus Conference on Brain Tumor Definition for registration. November 10, 2000","volume":"4","author":"McCarthy","year":"2000","journal-title":"Neuro Oncol"},{"issue":"1","key":"2025101611114398300_CIT0020","first-page":"vdaa175","article-title":"An updated histology recode for the analysis of primary malignant and nonmalignant brain and other central nervous system tumors in the Surveillance, Epidemiology, and End Results Program","volume":"3","author":"Forjaz","year":"2021","journal-title":"Neurooncol Adv"},{"issue":"4","key":"2025101611114398300_CIT0021","first-page":"139","article-title":"The Central Brain Tumor Registry of the United States Histopathological Grouping Scheme Provides Clinically Relevant Brain and Other Central Nervous System Categories for Cancer Registry Data","volume":"49","author":"Ostrom","year":"2022","journal-title":"J. Registry. Manag"},{"issue":"1","key":"2025101611114398300_CIT0022","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11060-016-2217-7","article-title":"Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying)","volume":"130","author":"Ostrom","year":"2016","journal-title":"J. Neurooncol"},{"issue":"11","key":"2025101611114398300_CIT0023","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/neuonc\/noac113","article-title":"Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States","volume":"24","author":"Iorgulescu","year":"2022","journal-title":"Neuro Oncol"},{"key":"2025101611114398300_CIT0024","volume-title":"States CBTRotU. SEER*Stat Database: CBTRUS Analytic File 1995-2022 (Includes PR and County-level data) - Linked To County Attributes - Total U.S., 1969-2023 Counties","year":"2025"},{"issue":"6","key":"2025101611114398300_CIT0025","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0962280206070621","article-title":"Efficient interval estimation for age-adjusted cancer rates","volume":"15","author":"Tiwari","year":"2006","journal-title":"Stat. Methods Med. Res"},{"issue":"6","key":"2025101611114398300_CIT0026","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0962280206070621","article-title":"Efficient interval estimation for age-adjusted cancer rates","volume":"15","author":"Tiwari","year":"2006","journal-title":"Stat. Methods Med. Res"},{"key":"2025101611114398300_CIT0027","volume-title":"SEER*Stat Database: Populations - Total U.S. (1990-2023) &lt;Katrina\/Rita Adjustment&gt; - Linked To County Attributes - Total U.S., 1969-2023 Counties","author":"Surveillance Epidemiology and End Results (SEER) Program","year":"2025"},{"issue":"9","key":"2025101611114398300_CIT0028","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1080\/03610929908832411","article-title":"Approximate confidence intervals for rate ratios from directly standardized rates with sparse data","volume":"28","author":"Fay","year":"1999","journal-title":"Communications in Statistics - Theory and Methods"},{"key":"2025101611114398300_CIT0029","article-title":"SEER*Stat Database: NPCR and SEER Incidence - U.S. Cancer Statistics Public Use Research Database, 2024 Submission (2001-2022)","author":"National Program of Cancer Registries and Surveillance Epidemiology and End Results Program","year":"2025"},{"key":"2025101611114398300_CIT0030","volume-title":"Joinpoint Regression Program, Version 5.4.0 - April 2025; Statistical Methodology and Applications Branch","year":"2025"},{"issue":"19","key":"2025101611114398300_CIT0031","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","author":"Kim","year":"2000","journal-title":"Stat. Med"},{"key":"2025101611114398300_CIT0032","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016\u20142020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro Oncol"},{"issue":"16","key":"2025101611114398300_CIT0033","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1002\/cncr.34837","article-title":"Complete prevalence of primary malignant and nonmalignant brain tumors in comparison to other cancers in the United States","volume":"129","author":"Neff","year":"2023","journal-title":"Cancer"},{"key":"2025101611114398300_CIT0034","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noy002","article-title":"Females have the survival advantage in glioblastoma","author":"Ostrom","year":"2018","journal-title":"Neuro-oncology"},{"issue":"9","key":"2025101611114398300_CIT0035","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jamaoncol.2018.1789","article-title":"Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014","volume":"4","author":"Ostrom","year":"2018","journal-title":"JAMA Oncol"},{"key":"2025101611114398300_CIT0036","doi-asserted-by":"crossref","DOI":"10.1093\/nop\/npz019","article-title":"Sex is an important prognostic factor for glioblastoma but not for nonglioblastoma","author":"Gittleman","year":"2019","journal-title":"Neuro-Oncology Practice"},{"key":"2025101611114398300_CIT0037","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noaf142","article-title":"Years of life lost due to central nervous system tumor subtypes in the United States","author":"Gerstl","year":"2025","journal-title":"Neuro Oncol"},{"issue":"49","key":"2025101611114398300_CIT0038","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/jncimonographs\/lgu018","article-title":"Evaluation of North American Association of Central Cancer Registries\u2019 (NAACCR) data for use in population-based cancer survival studies","volume":"2014","author":"Weir","year":"2014","journal-title":"J. Natl. Cancer Inst. Monogr"},{"issue":"2","key":"2025101611114398300_CIT0039","first-page":"65","article-title":"Coding completeness and quality of relative survival-related variables in the National Program of Cancer Registries Cancer Surveillance System, 1995-2008","volume":"41","author":"Wilson","year":"2014","journal-title":"J. Registry. Manag"},{"key":"2025101611114398300_CIT0040","volume-title":"WHO Classification of Tumours of the Central Nervous System","author":"Louis","year":"2007"},{"key":"2025101611114398300_CIT0041","volume-title":"Tumours of the nervous system: World Health Organization classification of tumours","author":"Kleihues","year":"2000"},{"issue":"3","key":"2025101611114398300_CIT0042","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1750-3639.1993.tb00752.x","article-title":"The new WHO classification of brain tumours","volume":"3","author":"Kleihues","year":"1993","journal-title":"Brain Pathol"},{"issue":"8","key":"2025101611114398300_CIT0043","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"3","key":"2025101611114398300_CIT0044","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00401-010-0725-7","article-title":"Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician\u2019s perspective","volume":"120","author":"van den Bent","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"6","key":"2025101611114398300_CIT0045","first-page":"52","article-title":"Evaluate job to set compensation","volume":"4","author":"Plachy","year":"1975","journal-title":"Mod. Healthc"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/27\/Supplement_4\/iv1\/64702229\/noaf194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/27\/Supplement_4\/iv1\/64702229\/noaf194.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:11:58Z","timestamp":1760627518000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/27\/Supplement_4\/iv1\/8285946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":45,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2025,10,14]]},"published-print":{"date-parts":[[2025,10,14]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noaf194","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,10]]}}}